NYC Doc Arrested in Protest; Ozzy Osbourne's Stem Cell Tx; Metformin and COVID
(MedPage Today) -- Note that some links may require registration or subscription.
A primary care doctor reportedly was injured when he was among the mass arrests for protesting at City College in New York City. (amNY)
A U.S. vascular surgeon... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 2, 2024 Category: Infectious Diseases Source Type: news
Is Ozempic the New Anti-Inflammatory Wonder Drug?
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn’s disease as a teenager, the multiple operations she had endured to remove diseased parts of her bowels, and the array of symptoms she suffered with, including nausea, a dozen bowel movements a day, and a total reliance on nutrition obtained through her veins, known as total parenteral nutrition (TPN). Instead of twenty feet of small intestines that most people hav...
Source: TIME: Health - April 30, 2024 Category: Consumer Health News Authors: Shilpa Ravella Tags: Uncategorized freelance Source Type: news
A 20-cent pill discovered in 1950s could be secret to anti-aging - as scientists launch trial involving 3,000 people
Researchers at the American Federation for Aging Research are launching the TAME trial, a six-year series of studies aimed to see if cheap diabetes drug Metformin can increase lifespan. (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2024 Category: Consumer Health News Source Type: news
A cheap drug may slow down aging. A study will determine if it works
Studies suggest people who take metformin for diabetes may be at lower risk for cancer, heart disease and dementia. Now researchers aim to test if it prevents age-related diseases in healthy people. (Source: NPR Health and Science)
Source: NPR Health and Science - April 22, 2024 Category: Consumer Health News Authors: Allison Aubrey Source Type: news
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?
(MedPage Today) -- Bexagliflozin (Brenzavvy) and dapagliflozin (Farxiga) induced similar HbA1c reductions over 24 weeks in a head-to-head phase III trial of the SGLT2 inhibitors in Chinese adults with type 2 diabetes on metformin. (Journal of Diabetes... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 16, 2024 Category: Endocrinology Source Type: news
Rigorous Detection of Nitrosamine Contaminants in Metformin Products: Balancing Product Safety and Product Accessibility
Nitrosamines are a class of chemicals that commonly occur as impurities in water, beverages, and foods (particularly in cured and grilled meats). Although nitrosamines are generally regarded to be carcinogenic, small amounts of exposure are not considered to be harmful. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 12, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Effect of Metformin Across Renal Function States in Diabetes Effect of Metformin Across Renal Function States in Diabetes
Metformin lowered cardiovascular and renal risk in patients with type 2 diabetes across distinct renal function states, including patients considered contraindicated.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 5, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Is Metformin a'Drug for All Diseases'? Is Metformin a'Drug for All Diseases'?
Metformin, a staple of glucose management for decades, is now being studied for use in a wide range of diseases from carotid atherosclerosis to vitiligo.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 27, 2024 Category: Drugs & Pharmacology Tags: Internal Medicine Source Type: news
Metformin Shows Potential to Prevent Neovascular AMD Metformin Shows Potential to Prevent Neovascular AMD
A case-control study of 174,000 individuals found that use of metformin was associated with a reduced odds of developing wet, age-related macular degeneration.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 23, 2024 Category: Consumer Health News Tags: Ophthalmology Source Type: news
Metformin Added to Insulin Not Beneficial for T2D in Pregnancy
TUESDAY, Dec. 12, 2023 -- For pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec. 12 issue of the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2023 Category: Pharmaceuticals Source Type: news
Metformin for Diabetes in Pregnancy: Maybe Not, Trial Says
(MedPage Today) -- Adding metformin to insulin treatment for pregnant women with preexisting type 2 or gestational diabetes did not reduce composite neonatal adverse outcomes, according to the randomized MOMPOD trial.
The composite outcome -... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 12, 2023 Category: Urology & Nephrology Source Type: news
Metformin Linked to Lower Odds of Developing AMD in Non-Diabetic Patients
(MedPage Today) -- Use of metformin was associated with lower odds of developing age-related macular degeneration (AMD) among patients without a diabetes diagnosis, offering more evidence of a possible role for the inexpensive drug in eye health... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 7, 2023 Category: Endocrinology Source Type: news
Why ‘ Healthspan ’ May Be More Important Than Lifespan
In 2014, then-57-year-old bioethicist Dr. Ezekiel Emanuel wrote an infamous essay titled, “Why I Hope to Die at 75” for The Atlantic. His argument boiled down to this: it’s not worth living as long as humanly possible if those efforts yield extra decades defined by disease and poor health, which data suggest is the fate awaiting many people in the U.S.
Nearly a decade later, neither Emanuel’s mind nor the statistics have changed much. Emanuel still says he plans to stop most life-extending medical care once he reaches age 75, though he’s healthy enough that he expects to live longer natural...
Source: TIME: Health - November 30, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin
Maryland Heights, MO, SugarMDs, LLC is voluntarily recalling Lot: 22165-003 Advance Glucose Support Supplement in 60, 120 and 180 count bottles to the consumer level. FDA analysis has found the product to be tainted with glyburide and metformin. Glyburide and Metformin are active ingredients found (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 29, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd
(MedPage Today) -- The FDA announced a voluntary recall of an over-the-counter glucose support supplement for the presence of metformin and glyburide.
Over the past two decades, the prevalence of diabetes and obesity, respectively, increased from... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 21, 2023 Category: Endocrinology Source Type: news
